Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03398135




Registration number
Help: Registration number
NCT03398135
Ethics application status
Help: Ethics application status
Date submitted
Help: Date submitted
8/01/2018
Date registered
Help: Date registered
12/01/2018
Date last updated
Help: Date last updated
20/01/2026

Titles & IDs
Public title
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Scientific title
A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis
Additional trial identifiers [1] 0 0
2023-506994-36-00
Additional trial identifiers [2] 0 0
M16-066
Universal Trial Number (UTN)
Trial acronym
COMMAND
Related trial records

Health condition
Health condition(s) studied:
Ulcerative Colitis (UC) 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Treatment: Drugs - risankizumab
Treatment: Drugs - placebo for risankizumab

Placebo comparator: Substudy 1: Double-blind Placebo - Participants randomized to receive placebo for risankizumab administered by subcutaneous (SC) injection.

Experimental: Substudy 1: Double-blind Risankizumab Dose 1 - Participants randomized to receive risankizumab dose 1 administered by subcutaneous (SC) injection.

Experimental: Substudy 1: Double-blind Risankizumab Dose 2 - Participants randomized to receive risankizumab dose 2 administered by subcutaneous (SC) injection.

Experimental: Substudy 2: Open-label (OL) Clinical Assessment Risankizumab - Participants randomized to receive risankizumab dose 1 administered by subcutaneous (SC) injection.

Experimental: Substudy 2: OL Therapeutic Drug Monitoring Risankizumab - Participants randomized to receive risankizumab dose 1 administered by subcutaneous (SC) injection.

Experimental: Substudy 3: OL Extension Risankizumab - Participants who completed Sub-study 1 or 2 receive open-label risankizumab in Sub-study 3.

Experimental: OL Continuous Treatment Extension - Dose 1 - Participants who complete Sub-study 3 and continue to tolerate and derive benefit from receiving risankizumab, will continue to receive risankizumab based on their assignment during Sub-study 3. Participants completing Sub-study 3 without receiving risankizumab rescue therapy in any sub-study will receive risankizumab Dose 1 administered by subcutaneous (SC) injection.

Experimental: OL Continuous Treatment Extension - Dose 2 - Participants who complete Sub-study 3 and continue to tolerate and derive benefit from receiving risankizumab, will continue to receive risankizumab based on their assignment during Sub-study 3. Participants completing Sub-study 3 and received risankizumab rescue therapy in any sub-study will receive risankizumab Dose 2 administered by subcutaneous (SC) injection.


Treatment: Drugs: risankizumab
subcutaneous (SC) injection

Treatment: Drugs: placebo for risankizumab
subcutaneous (SC) injection
Intervention code [1] 0 0
Treatment: Drugs
Description of the comparator or control
Control group

Outcomes
Primary outcome [1] 0 0
Sub-Study 1: Percentage of Participants Achieving Clinical Remission per Adapted Mayo Score
Timepoint [1] 0 0
Week 52
Primary outcome [2] 0 0
Percentage of Participants with Adverse Events (AE)
Timepoint [2] 0 0
Up to Week 300
Secondary outcome [1] 0 0
Sub-Study 1: Percentage of Participants Achieving Endoscopic Improvement
Timepoint [1] 0 0
Week 52
Secondary outcome [2] 0 0
Sub-Study 1: Percentage of Participants Achieving Histologic-Endoscopic Mucosal Improvement
Timepoint [2] 0 0
Week 52
Secondary outcome [3] 0 0
Sub-Study 1: Percentage of Participants Achieving Endoscopic Remission
Timepoint [3] 0 0
Week 52
Secondary outcome [4] 0 0
Sub-Study 1: Percentage of Participants with Clinical Remission per Adapted Mayo Score in Participants with no Corticosteroid Use for 90 days
Timepoint [4] 0 0
Week 52
Secondary outcome [5] 0 0
Sub-Study 1: Percentage of Participants with Clinical Remission per Adapted Mayo Score in Participants with a Clinical Remission at Week 0
Timepoint [5] 0 0
Week 52
Secondary outcome [6] 0 0
Sub-Study 1: Percentage of Participants Achieving No Bowel Urgency
Timepoint [6] 0 0
Week 52
Secondary outcome [7] 0 0
Sub-Study 1: Percentage of Participants Achieving No Abdominal Pain
Timepoint [7] 0 0
Week 52
Secondary outcome [8] 0 0
Sub-Study 1: Percentage of Participants Achieving Histologic-Endoscopic Mucosal Remission
Timepoint [8] 0 0
Week 52
Secondary outcome [9] 0 0
Sub-Study 1: Percentage of Participants Achieving Endoscopic Improvement in Participants with Endoscopic Improvement at Week 0
Timepoint [9] 0 0
Week 52
Secondary outcome [10] 0 0
Sub-Study 1: Percentage of Participants Achieving Clinical Response per Adapted Mayo Score
Timepoint [10] 0 0
Week 52
Secondary outcome [11] 0 0
Sub-Study 1: Change in Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue)
Timepoint [11] 0 0
Week 0 to Week 52
Secondary outcome [12] 0 0
Sub-Study 1: Change in Inflammatory Bowel Disease Questionnaire (IBDQ)
Timepoint [12] 0 0
Baseline (Week 0) to Week 52
Secondary outcome [13] 0 0
Sub-Study 1: Percentage of Participants Achieving No Nocturnal Bowel Movements
Timepoint [13] 0 0
Week 52
Secondary outcome [14] 0 0
Sub-Study 1: Percentage of Participants Achieving No Tenesmus
Timepoint [14] 0 0
Week 52
Secondary outcome [15] 0 0
Sub-Study 1: Change in Number of Fecal Incontinence Episodes per Week
Timepoint [15] 0 0
Baseline (Week 0) to Week 52
Secondary outcome [16] 0 0
Sub-Study 1: Change in Number of Days per Week with Sleep Interrupted due to UC Symptoms
Timepoint [16] 0 0
Baseline (Week 0) to Week 52
Secondary outcome [17] 0 0
Sub-Study 1: Percentage of Participants with Exposure Adjusted Occurrence of Ulcerative Colitis (UC) Related Hospitalization
Timepoint [17] 0 0
Through Week 52

Eligibility
Key inclusion criteria
- Participants who have completed Study M16-067 and have achieved clinical response as defined in the protocol.
Minimum age
16 Years
Maximum age
80 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
* Participants who have a known hypersensitivity to risankizumab or the excipients of any of the study drugs or the ingredients of chinese hamster ovary (CHO) or had an adverse event (AE) during Studies M16-067 that in the Investigator's judgment makes the participant unsuitable for this study.
* Participant is considered by the Investigator, for any reason, to be an unsuitable candidate for the study.
* Participant is not in compliance with prior and concomitant medication requirements throughout Studies M16-067.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
28/08/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/02/2029
Actual
Sample size
Target
Accrual to date
Final
1242
Recruitment in Australia
Recruitment state(s)
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Colorado
Country [3] 0 0
United States of America
State/province [3] 0 0
Connecticut
Country [4] 0 0
United States of America
State/province [4] 0 0
Florida
Country [5] 0 0
United States of America
State/province [5] 0 0
Georgia
Country [6] 0 0
United States of America
State/province [6] 0 0
Illinois
Country [7] 0 0
United States of America
State/province [7] 0 0
Indiana
Country [8] 0 0
United States of America
State/province [8] 0 0
Kansas
Country [9] 0 0
United States of America
State/province [9] 0 0
Kentucky
Country [10] 0 0
United States of America
State/province [10] 0 0
Louisiana
Country [11] 0 0
United States of America
State/province [11] 0 0
Massachusetts
Country [12] 0 0
United States of America
State/province [12] 0 0
Michigan
Country [13] 0 0
United States of America
State/province [13] 0 0
Minnesota
Country [14] 0 0
United States of America
State/province [14] 0 0
Nebraska
Country [15] 0 0
United States of America
State/province [15] 0 0
New York
Country [16] 0 0
United States of America
State/province [16] 0 0
North Carolina
Country [17] 0 0
United States of America
State/province [17] 0 0
North Dakota
Country [18] 0 0
United States of America
State/province [18] 0 0
Ohio
Country [19] 0 0
United States of America
State/province [19] 0 0
Oklahoma
Country [20] 0 0
United States of America
State/province [20] 0 0
Pennsylvania
Country [21] 0 0
United States of America
State/province [21] 0 0
South Carolina
Country [22] 0 0
United States of America
State/province [22] 0 0
Tennessee
Country [23] 0 0
United States of America
State/province [23] 0 0
Texas
Country [24] 0 0
United States of America
State/province [24] 0 0
Utah
Country [25] 0 0
United States of America
State/province [25] 0 0
Virginia
Country [26] 0 0
United States of America
State/province [26] 0 0
Washington
Country [27] 0 0
Argentina
State/province [27] 0 0
Buenos Aires
Country [28] 0 0
Argentina
State/province [28] 0 0
Buenos Aires F.D.
Country [29] 0 0
Argentina
State/province [29] 0 0
Santa Fe Province
Country [30] 0 0
Argentina
State/province [30] 0 0
Tucumán Province
Country [31] 0 0
Argentina
State/province [31] 0 0
Córdoba
Country [32] 0 0
Austria
State/province [32] 0 0
Lower Austria
Country [33] 0 0
Austria
State/province [33] 0 0
Styria
Country [34] 0 0
Austria
State/province [34] 0 0
Upper Austria
Country [35] 0 0
Austria
State/province [35] 0 0
Vienna
Country [36] 0 0
Austria
State/province [36] 0 0
Salzburg
Country [37] 0 0
Belgium
State/province [37] 0 0
Antwerpen
Country [38] 0 0
Belgium
State/province [38] 0 0
Brussels Capital
Country [39] 0 0
Belgium
State/province [39] 0 0
Liege
Country [40] 0 0
Belgium
State/province [40] 0 0
Namur
Country [41] 0 0
Belgium
State/province [41] 0 0
Vlaams-Brabant
Country [42] 0 0
Belgium
State/province [42] 0 0
West-Vlaanderen
Country [43] 0 0
Belgium
State/province [43] 0 0
Liège
Country [44] 0 0
Brazil
State/province [44] 0 0
Goiás
Country [45] 0 0
Brazil
State/province [45] 0 0
La Spezia
Country [46] 0 0
Brazil
State/province [46] 0 0
Paraná
Country [47] 0 0
Brazil
State/province [47] 0 0
Rio Grande do Sul
Country [48] 0 0
Brazil
State/province [48] 0 0
São Paulo
Country [49] 0 0
Bulgaria
State/province [49] 0 0
Sofia
Country [50] 0 0
Bulgaria
State/province [50] 0 0
Plovdiv
Country [51] 0 0
Bulgaria
State/province [51] 0 0
Sliven
Country [52] 0 0
Canada
State/province [52] 0 0
Alberta
Country [53] 0 0
Canada
State/province [53] 0 0
British Columbia
Country [54] 0 0
Canada
State/province [54] 0 0
Ontario
Country [55] 0 0
Canada
State/province [55] 0 0
Quebec
Country [56] 0 0
Chile
State/province [56] 0 0
Bio-Bio
Country [57] 0 0
Chile
State/province [57] 0 0
Región de la Araucanía
Country [58] 0 0
Chile
State/province [58] 0 0
Santiago Metropolitan
Country [59] 0 0
China
State/province [59] 0 0
Anhui
Country [60] 0 0
China
State/province [60] 0 0
Beijing Municipality
Country [61] 0 0
China
State/province [61] 0 0
Guangdong
Country [62] 0 0
China
State/province [62] 0 0
Hebei
Country [63] 0 0
China
State/province [63] 0 0
Hubei
Country [64] 0 0
China
State/province [64] 0 0
Hunan
Country [65] 0 0
China
State/province [65] 0 0
Jiangsu
Country [66] 0 0
China
State/province [66] 0 0
Jiangxi
Country [67] 0 0
China
State/province [67] 0 0
Jilin
Country [68] 0 0
China
State/province [68] 0 0
Liaoning
Country [69] 0 0
China
State/province [69] 0 0
Ningxia
Country [70] 0 0
China
State/province [70] 0 0
Shaanxi
Country [71] 0 0
China
State/province [71] 0 0
Shanghai Municipality
Country [72] 0 0
China
State/province [72] 0 0
Shanxi
Country [73] 0 0
China
State/province [73] 0 0
Sichuan
Country [74] 0 0
China
State/province [74] 0 0
Zhejiang
Country [75] 0 0
Colombia
State/province [75] 0 0
Antioquia
Country [76] 0 0
Colombia
State/province [76] 0 0
Cundinamarca
Country [77] 0 0
Colombia
State/province [77] 0 0
Departamento de Córdoba
Country [78] 0 0
Croatia
State/province [78] 0 0
City of Zagreb
Country [79] 0 0
Croatia
State/province [79] 0 0
County of Osijek-Baranja
Country [80] 0 0
Croatia
State/province [80] 0 0
Split-Dalmatia County
Country [81] 0 0
Czechia
State/province [81] 0 0
Brno-mesto
Country [82] 0 0
Czechia
State/province [82] 0 0
Ostrava-mesto
Country [83] 0 0
Czechia
State/province [83] 0 0
South Moravian
Country [84] 0 0
Czechia
State/province [84] 0 0
Ceské Budejovice
Country [85] 0 0
Czechia
State/province [85] 0 0
Hradec Králové
Country [86] 0 0
Denmark
State/province [86] 0 0
Capital Region
Country [87] 0 0
Denmark
State/province [87] 0 0
Region Sjælland
Country [88] 0 0
Denmark
State/province [88] 0 0
Region Syddanmark
Country [89] 0 0
Egypt
State/province [89] 0 0
Alexandria Governorate
Country [90] 0 0
Egypt
State/province [90] 0 0
Monufia Governorate
Country [91] 0 0
Egypt
State/province [91] 0 0
Alexandria
Country [92] 0 0
Egypt
State/province [92] 0 0
Cairo
Country [93] 0 0
France
State/province [93] 0 0
Alpes-Maritimes
Country [94] 0 0
France
State/province [94] 0 0
Bouches-du-Rhone
Country [95] 0 0
France
State/province [95] 0 0
Herault
Country [96] 0 0
France
State/province [96] 0 0
Meurthe-et-Moselle
Country [97] 0 0
France
State/province [97] 0 0
Nouvelle-Aquitaine
Country [98] 0 0
France
State/province [98] 0 0
Pays de la Loire Region
Country [99] 0 0
France
State/province [99] 0 0
Somme
Country [100] 0 0
France
State/province [100] 0 0
Nantes
Country [101] 0 0
France
State/province [101] 0 0
Île-de-France Region
Country [102] 0 0
Germany
State/province [102] 0 0
Baden-Wurttemberg
Country [103] 0 0
Germany
State/province [103] 0 0
Bavaria
Country [104] 0 0
Germany
State/province [104] 0 0
Hesse
Country [105] 0 0
Germany
State/province [105] 0 0
Lower Saxony
Country [106] 0 0
Germany
State/province [106] 0 0
North Rhine-Westphalia
Country [107] 0 0
Germany
State/province [107] 0 0
Saxony
Country [108] 0 0
Germany
State/province [108] 0 0
Schleswig-Holstein
Country [109] 0 0
Germany
State/province [109] 0 0
Berlin
Country [110] 0 0
Germany
State/province [110] 0 0
Braunschweig
Country [111] 0 0
Germany
State/province [111] 0 0
Regensburg
Country [112] 0 0
Greece
State/province [112] 0 0
Attica
Country [113] 0 0
Greece
State/province [113] 0 0
Crete
Country [114] 0 0
Greece
State/province [114] 0 0
Athens
Country [115] 0 0
Greece
State/province [115] 0 0
Thessaloniki
Country [116] 0 0
Israel
State/province [116] 0 0
Jerusalem
Country [117] 0 0
Israel
State/province [117] 0 0
Southern District
Country [118] 0 0
Israel
State/province [118] 0 0
Tel Aviv
Country [119] 0 0
Israel
State/province [119] 0 0
Haifa
Country [120] 0 0
Israel
State/province [120] 0 0
Petah Tikva
Country [121] 0 0
Italy
State/province [121] 0 0
Genova
Country [122] 0 0
Italy
State/province [122] 0 0
Lombardy
Country [123] 0 0
Italy
State/province [123] 0 0
Milano
Country [124] 0 0
Italy
State/province [124] 0 0
Roma
Country [125] 0 0
Italy
State/province [125] 0 0
Verona
Country [126] 0 0
Italy
State/province [126] 0 0
Bologna
Country [127] 0 0
Italy
State/province [127] 0 0
Catania
Country [128] 0 0
Italy
State/province [128] 0 0
Catanzaro
Country [129] 0 0
Italy
State/province [129] 0 0
Modena
Country [130] 0 0
Italy
State/province [130] 0 0
Rome
Country [131] 0 0
Japan
State/province [131] 0 0
Aichi-ken
Country [132] 0 0
Japan
State/province [132] 0 0
Aomori
Country [133] 0 0
Japan
State/province [133] 0 0
Chiba
Country [134] 0 0
Japan
State/province [134] 0 0
Fukuoka
Country [135] 0 0
Japan
State/province [135] 0 0
Gifu
Country [136] 0 0
Japan
State/province [136] 0 0
Gunma
Country [137] 0 0
Japan
State/province [137] 0 0
Hiroshima
Country [138] 0 0
Japan
State/province [138] 0 0
Hokkaido
Country [139] 0 0
Japan
State/province [139] 0 0
Hyogo
Country [140] 0 0
Japan
State/province [140] 0 0
Ishikawa-ken
Country [141] 0 0
Japan
State/province [141] 0 0
Kagoshima-ken
Country [142] 0 0
Japan
State/province [142] 0 0
Kanagawa
Country [143] 0 0
Japan
State/province [143] 0 0
Mie-ken
Country [144] 0 0
Japan
State/province [144] 0 0
Miyagi
Country [145] 0 0
Japan
State/province [145] 0 0
Nagasaki
Country [146] 0 0
Japan
State/province [146] 0 0
Nara
Country [147] 0 0
Japan
State/province [147] 0 0
Osaka
Country [148] 0 0
Japan
State/province [148] 0 0
Saga-ken
Country [149] 0 0
Japan
State/province [149] 0 0
Saitama
Country [150] 0 0
Japan
State/province [150] 0 0
Shiga
Country [151] 0 0
Japan
State/province [151] 0 0
Shizuoka
Country [152] 0 0
Japan
State/province [152] 0 0
Tokyo
Country [153] 0 0
Japan
State/province [153] 0 0
Wakayama
Country [154] 0 0
Japan
State/province [154] 0 0
Yamagata
Country [155] 0 0
Japan
State/province [155] 0 0
Yamaguchi
Country [156] 0 0
Latvia
State/province [156] 0 0
Riga
Country [157] 0 0
Lithuania
State/province [157] 0 0
Kaunas
Country [158] 0 0
Lithuania
State/province [158] 0 0
Vilnius
Country [159] 0 0
Mexico
State/province [159] 0 0
Morelos
Country [160] 0 0
Mexico
State/province [160] 0 0
Yucatán
Country [161] 0 0
Mexico
State/province [161] 0 0
Del. Benito Juárez
Country [162] 0 0
Netherlands
State/province [162] 0 0
North Brabant
Country [163] 0 0
Netherlands
State/province [163] 0 0
North Holland
Country [164] 0 0
New Zealand
State/province [164] 0 0
Bay of Plenty
Country [165] 0 0
New Zealand
State/province [165] 0 0
Canterbury
Country [166] 0 0
New Zealand
State/province [166] 0 0
Otago
Country [167] 0 0
New Zealand
State/province [167] 0 0
Waikato Region
Country [168] 0 0
New Zealand
State/province [168] 0 0
Wellington Region
Country [169] 0 0
Poland
State/province [169] 0 0
Kuyavian-Pomeranian Voivodeship
Country [170] 0 0
Poland
State/province [170] 0 0
Lesser Poland Voivodeship
Country [171] 0 0
Poland
State/province [171] 0 0
Lower Silesian Voivodeship
Country [172] 0 0
Poland
State/province [172] 0 0
Masovian Voivodeship
Country [173] 0 0
Poland
State/province [173] 0 0
Pomeranian Voivodeship
Country [174] 0 0
Poland
State/province [174] 0 0
Silesian Voivodeship
Country [175] 0 0
Portugal
State/province [175] 0 0
Braga District
Country [176] 0 0
Portugal
State/province [176] 0 0
Faro District
Country [177] 0 0
Portugal
State/province [177] 0 0
Porto District
Country [178] 0 0
Portugal
State/province [178] 0 0
Setúbal District
Country [179] 0 0
Portugal
State/province [179] 0 0
Coimbra
Country [180] 0 0
Portugal
State/province [180] 0 0
Lisbon
Country [181] 0 0
Portugal
State/province [181] 0 0
Porto
Country [182] 0 0
Portugal
State/province [182] 0 0
Viseu
Country [183] 0 0
Puerto Rico
State/province [183] 0 0
Ponce
Country [184] 0 0
Puerto Rico
State/province [184] 0 0
San Juan
Country [185] 0 0
Romania
State/province [185] 0 0
Cluj
Country [186] 0 0
Romania
State/province [186] 0 0
Bucharest
Country [187] 0 0
Romania
State/province [187] 0 0
Timi?oara
Country [188] 0 0
Russia
State/province [188] 0 0
Kabardino-Balkarskaya Respublika
Country [189] 0 0
Russia
State/province [189] 0 0
Kaliningrad Oblast
Country [190] 0 0
Russia
State/province [190] 0 0
Kemerovo Oblast
Country [191] 0 0
Russia
State/province [191] 0 0
Leningradskaya Oblast'
Country [192] 0 0
Russia
State/province [192] 0 0
Moscow Oblast
Country [193] 0 0
Russia
State/province [193] 0 0
Novosibirsk Oblast
Country [194] 0 0
Russia
State/province [194] 0 0
Permskiy Kray
Country [195] 0 0
Russia
State/province [195] 0 0
Sankt-Peterburg
Country [196] 0 0
Russia
State/province [196] 0 0
Tyumen Oblast
Country [197] 0 0
Russia
State/province [197] 0 0
Dzerzhinskiy
Country [198] 0 0
Russia
State/province [198] 0 0
Moscow
Country [199] 0 0
Russia
State/province [199] 0 0
Pushkin
Country [200] 0 0
Russia
State/province [200] 0 0
Saint Petersburg
Country [201] 0 0
Russia
State/province [201] 0 0
Ulyanovsk
Country [202] 0 0
Serbia
State/province [202] 0 0
Beograd
Country [203] 0 0
Serbia
State/province [203] 0 0
Jablanicki Okrug
Country [204] 0 0
Serbia
State/province [204] 0 0
Vojvodina
Country [205] 0 0
Singapore
State/province [205] 0 0
Central Singapore
Country [206] 0 0
Slovakia
State/province [206] 0 0
Banská Bystrica Region
Country [207] 0 0
Slovakia
State/province [207] 0 0
Nitra Region
Country [208] 0 0
Slovakia
State/province [208] 0 0
Presov
Country [209] 0 0
Slovenia
State/province [209] 0 0
Ljubljana
Country [210] 0 0
South Africa
State/province [210] 0 0
Free State
Country [211] 0 0
South Africa
State/province [211] 0 0
Gauteng
Country [212] 0 0
South Africa
State/province [212] 0 0
Western Cape
Country [213] 0 0
South Korea
State/province [213] 0 0
Busan Gwang Yeogsi
Country [214] 0 0
South Korea
State/province [214] 0 0
Daejeon Gwang Yeogsi
Country [215] 0 0
South Korea
State/province [215] 0 0
Gyeonggido
Country [216] 0 0
South Korea
State/province [216] 0 0
Seoul Teugbyeolsi
Country [217] 0 0
South Korea
State/province [217] 0 0
Daegu
Country [218] 0 0
South Korea
State/province [218] 0 0
Seoul
Country [219] 0 0
Spain
State/province [219] 0 0
A Coruna
Country [220] 0 0
Spain
State/province [220] 0 0
Barcelona
Country [221] 0 0
Spain
State/province [221] 0 0
Madrid
Country [222] 0 0
Spain
State/province [222] 0 0
Pontevedra
Country [223] 0 0
Spain
State/province [223] 0 0
Principality of Asturias
Country [224] 0 0
Spain
State/province [224] 0 0
Córdoba
Country [225] 0 0
Spain
State/province [225] 0 0
Salamanca
Country [226] 0 0
Spain
State/province [226] 0 0
Seville
Country [227] 0 0
Spain
State/province [227] 0 0
Zaragoza
Country [228] 0 0
Sweden
State/province [228] 0 0
Västra Götaland County
Country [229] 0 0
Sweden
State/province [229] 0 0
Stockholm
Country [230] 0 0
Switzerland
State/province [230] 0 0
Canton of Zurich
Country [231] 0 0
Switzerland
State/province [231] 0 0
Bern
Country [232] 0 0
Taiwan
State/province [232] 0 0
Taipei
Country [233] 0 0
Taiwan
State/province [233] 0 0
Taichung
Country [234] 0 0
Taiwan
State/province [234] 0 0
Taoyuan
Country [235] 0 0
Turkey (Türkiye)
State/province [235] 0 0
Istanbul
Country [236] 0 0
Turkey (Türkiye)
State/province [236] 0 0
Kayseri
Country [237] 0 0
Turkey (Türkiye)
State/province [237] 0 0
Ankara
Country [238] 0 0
Turkey (Türkiye)
State/province [238] 0 0
Battalgazi/malatya
Country [239] 0 0
Turkey (Türkiye)
State/province [239] 0 0
Bursa
Country [240] 0 0
Turkey (Türkiye)
State/province [240] 0 0
Elâzig
Country [241] 0 0
Ukraine
State/province [241] 0 0
Ivano-Frankivsk
Country [242] 0 0
Ukraine
State/province [242] 0 0
Kherson
Country [243] 0 0
Ukraine
State/province [243] 0 0
Kyiv
Country [244] 0 0
United Kingdom
State/province [244] 0 0
Cambridgeshire
Country [245] 0 0
United Kingdom
State/province [245] 0 0
Devon
Country [246] 0 0
United Kingdom
State/province [246] 0 0
Edinburgh, City of
Country [247] 0 0
United Kingdom
State/province [247] 0 0
Greater London
Country [248] 0 0
United Kingdom
State/province [248] 0 0
Hampshire
Country [249] 0 0
United Kingdom
State/province [249] 0 0
Barnsley
Country [250] 0 0
United Kingdom
State/province [250] 0 0
Liverpool
Country [251] 0 0
United Kingdom
State/province [251] 0 0
Newcastle upon Tyne

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
AbbVie
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
ABBVIE INC.
Address 0 0
AbbVie
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.

Supporting document/s available: Study protocol, Statistical analysis plan (SAP)
When will data be available (start and end dates)?
For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/
Available to whom?
To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/
Available for what types of analyses?
How or where can data be obtained?
IPD available at link: https://vivli.org/ourmember/abbvie/


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT03398135